Abstract
Purpose
While cannabis is the most commonly used non-prescription drug in the USA and has established effects on weight, its implication for bariatric surgery has not been formally evaluated. We aimed to review the current literature on perioperative cannabis use in patients undergoing bariatric surgery.
Materials and Methods
Our systematic search of MEDLINE and Embase until March 2020 returned 169 citations. Screening and abstraction of results were performed in duplicate, and qualitative synthesis of the data was performed. Primary outcomes were cannabis use characteristics, weight loss outcomes, and 30-day postoperative morbidity. Study quality was assessed through the MINORS risk-of-bias tool.
Results
Six observational studies with a total of 1167 patients (78.6% female, median follow-up 12 months [3–38.4 months]) were included. A total of 9.9% of patients (n = 116/1167) used cannabis in the perioperative period. Compared with non-users, 1-year weight loss was significantly higher in a study evaluating 8 preoperative cannabis users (n = 8/239, p = 0.002); however, there were no differences in single-study data on 90-day total weight loss (n = 434, p = 0.89) nor 2-year excess BMI loss (n = 146, p = 0.631). There was no difference in 30-day minor (RR 0.91, 95%CI 0.49–1.71, p = 0.77) or major morbidity (RR 0.75, 95%CI 0.31–1.79; p = 0.50).
Conclusion
There are only uncontrolled studies to date on cannabis use in bariatric surgery. While these have reported conflicting effects on weight loss and no effect on morbidity to date, validation in randomized trials is required to facilitate evidence-based recommendations.
Similar content being viewed by others
References
Organization WH. Global status report on noncommunicable diseases 2014: World Health Organization; 2014.
Lehnert T, Sonntag D, Konnopka A, et al. Economic costs of overweight and obesity. Best Pract Res Clin Endocrinol Metab. Elsevier. 2013;27:105–15.
Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. Mass Medical Soc. 2004;351:2683–93.
Andersen JR, Aasprang A, Karlsen T-I, et al. Health-related quality of life after bariatric surgery: a systematic review of prospective long-term studies. Surg Obes Relat Dis Elsevier. 2015;11:466–73.
Campos GM, Khoraki J, Browning MG, et al. Changes in utilization of bariatric surgery in the United States from 1993 to 2016. Ann Surg LWW. 2020;271:201–9.
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. Springer. 2015;25:1822–32.
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. Springer. 2017;27:2279–89.
Flegal KM, Kruszon-Moran D, Carroll MD, et al. Trends in obesity among adults in the United States, 2005 to 2014. Jama. American Medical Association. 2016;315:2284–91.
Chang S-H, Stoll CRT, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA SurgAmerican Medical Association. 2014;149:275–87.
Elder KA, Wolfe BM. Bariatric surgery: a review of procedures and outcomes. Gastroenterology. 2007;132:2253–71. Available from: http://www.sciencedirect.com/science/article/pii/S0016508507005835. Accessed 15 June 2020.
Ehlers AP, Ghaferi AA. Bariatric surgery is safe and it works. JAMA Surg. American Medical Association. 2020;155:205.
Franks SF, Kaiser KA. Predictive factors in bariatric surgery outcomes: what is the role of the preoperative psychological evaluation. Prim Psychiatry MBL Communications. 2008;15:74–83.
Livhits M, Mercado C, Yermilov I, et al. Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg. 2012;22:70–89. Available from:. https://doi.org/10.1007/s11695-011-0472-4.
Li L, Wu L-T. Substance use after bariatric surgery: a review. J Psychiatr Res Elsevier. 2016;76:16–29.
Huson HB, Granados TM, Rasko Y. Surgical considerations of marijuana use in elective procedures. Heliyon. Elsevier. 2018a;4:e00779.
Sim-Selley LJ. Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids. Crit Rev Neurobiol. Begel House Inc. 2003;15:91–119.
Kirkham TC. Endocannabinoids in the regulation of appetite and body weight. Behav Pharmacol LWW. 2005;16:297–313.
Le Foll B, Trigo JM, Sharkey KA, et al. Cannabis and Δ9-tetrahydrocannabinol (THC) for weight loss? Med Hypotheses. Elsevier. 2013;80:564–7.
Sogg S. Alcohol misuse after bariatric surgery: epiphenomenon or “Oprah” phenomenon? Surg Obes Relat Dis. Elsevier. 2007;3:366–8.
Kruseman M, Leimgruber A, Zumbach F, et al. Dietary, weight, and psychological changes among patients with obesity, 8 years after gastric bypass. J Am Diet Assoc Elsevier. 2010;110:527–34.
Hoch E, Friemel C, Schneider M, et al. Efficacy and safety of medicinal cannabis: results of the CaPRis study. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2019.
Alshaarawy O, Anthony JC. Are cannabis users less likely to gain weight? Results from a national 3-year prospective study. Int J Epidemiol. Oxford University Press. 2019;48:1695–700.
Mücke M, Weier M, Carter C, et al. Systematic review and meta-analysis of cannabinoids in palliative medicine. J Cachexia Sarcopenia Muscle. Wiley Online Library. 2018;9:220–34.
Beulaygue IC, French MT. Got munchies? Estimating the relationship between marijuana use and body mass index. J Ment Health Policy Econ. 2016;19:123–40.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. Jama American Medical Association. 2004;292:1724–37.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009;62(10):e1–34.
Vidot DC, Prado G, De La Cruz-Munoz N, et al. Postoperative marijuana use and disordered eating among bariatric surgery patients. Surg Obes Relat Dis. 2016;12:171–8.
Almadani M, Harnsberger C, Broderick R, et al. Marijuana consumption leads to lower weight loss following laparoscopic sleeve gastrectomy. Soc Am Gastrointest Endosc Surg. 2015.
Shockcor N, Adnan SM, Siegel A, et al. Marijuana use does not affect the outcomes of bariatric surgery. Surg Endosc. 2020; Springer US. Available from:; https://doi.org/10.1007/s00464-020-07497-5.
Forner M, Nuño L, Gavotti GC, et al. Use of substances in obese patient candidates to bariatric surgery (Obenol project). Eur Psychiatry. 2018;375:S299–S300.
Mitchell JE, Steffen K, Engel S, et al. Addictive disorders after Roux-en-Y gastric bypass. Surg Obes Relat Dis. Elsevier. 2015;11:897–905. Available from:. https://doi.org/10.1016/j.soard.2014.10.026.
Bauer FL, Donahoo WT, Hollis Jr HW, et al. Marijuana’s influence on pain scores, initial weight loss, and other bariatric surgical outcomes. The Permanente Journal. 2018;22.
Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg Wiley Online Library. 2003;73:712–6.
Smit E, Crespo CJ. Dietary intake and nutritional status of US adult marijuana users: results from the Third National Health and Nutrition Examination Survey. Public Health Nutr. 2001;4:781–6. Cambridge University Press (CUP); Available from:. https://doi.org/10.1079/phn2000114.
Goel A, McGuinness B, Jivraj NK, et al. Cannabis use disorder and perioperative outcomes in major elective surgeries: a retrospective cohort analysis. Anesthesiol J Am Soc Anesthesiol. 2020;132:625–35. Available from:. https://doi.org/10.1097/ALN.0000000000003067.
Tetrault JM, Crothers K, Moore BA, et al. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med American Medical Association. 2007;167:221–8.
Aharonovich E, Liu X, Samet S, et al. Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study. Am J Psychiatry Am Psychiatric Assoc. 2005;162:1507–14.
Echeverria-Villalobos M, Todeschini AB, Stoicea N, et al. Perioperative care of cannabis users: a comprehensive review of pharmacological and anesthetic considerations. J Clin Anesth. 2019;57:41–9. Available from: http://www.sciencedirect.com/science/article/pii/S0952818018318026. Accessed 15 June 2020.
Akkucuk MH, Erbayrak M. A rare and unexpected side-effect of Cannabis use: abdominal pain due to acute pancreatitis. Loh CH, editor. Case Rep Emerg Med. 2015;2015:463836. Hindawi Publishing corporation. Available from:. https://doi.org/10.1155/2015/463836.
Buyukbese Sarsu S. Unusual side effect of cannabis use: acute abdomen due to duodenal perforation. Int J Emerg Med. 2016;9:18. 2016/07/07. Springer Berlin Heidelberg Available from: https://pubmed.ncbi.nlm.nih.gov/27387191. Accessed 08 June 2020.
Higa KD, Boone KB, Ho T. Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients-what have we learned? Obes Surg. Springer. 2000;10:509–13.
Westling A, Gustavsson S. Laparoscopic vs open Roux-en-Y gastric bypass: a prospective randomized trial. Obes Surg Springer. 2001;11:284–92.
Sacks BC, Mattar SG, Qureshi FG, et al. Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2:11–6. Available from: http://www.sciencedirect.com/science/article/pii/S155072890500897X. Accessed 15 June 2020.
Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity Wiley Online Library. 2013;21:S1–27.
Rummell CM, Heinberg LJ. Assessing marijuana use in bariatric surgery candidates: should it be a contraindication? Obes Surg. 2014;24:1764–70. Available from:. https://doi.org/10.1007/s11695-014-1315-x.
Huson HB, Granados TM, Rasko Y. Surgical considerations of marijuana use in elective procedures. Heliyon. 2018b;4(9):e00779. Available from:. https://doi.org/10.1016/j.heliyon.2018.e00779.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed Consent
None.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
ESM 1
(DOCX 14 kb)
Rights and permissions
About this article
Cite this article
Jung, F., Lee, Y., Manzoor, S. et al. Effects of Perioperative Cannabis Use on Bariatric Surgical Outcomes: a Systematic Review. OBES SURG 31, 299–306 (2021). https://doi.org/10.1007/s11695-020-04962-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-020-04962-x